- Home
- PLBY vs LUCD Comparison
PLBY vs LUCD Comparison
Compare PLBY & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLBY | LUCD |
|---|---|---|
| Founded | 1953 | 2018 |
| Country | United States | United States |
| Employees | N/A | 82 |
| Industry | Recreational Games/Products/Toys | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.4M | 198.4M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PLBY | LUCD |
|---|---|---|
| Price | $1.35 | $1.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $3.00 | ★ $4.13 |
| AVG Volume (30 Days) | 654.9K | ★ 1.2M |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.50 | 16.67 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $120,928,000.00 | $4,346,000.00 |
| Revenue This Year | $9.17 | $115.58 |
| Revenue Next Year | $7.10 | $130.54 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 4.13 | ★ 79.00 |
| 52 Week Low | $1.19 | $0.90 |
| 52 Week High | $2.75 | $1.63 |
Technical Indicators
Market Signals| Indicator | PLBY | LUCD |
|---|---|---|
| Relative Strength Index (RSI) | 46.71 | 55.82 |
| Support Level | $1.23 | $1.02 |
| Resistance Level | $1.48 | $1.12 |
| Average True Range (ATR) | 0.08 | 0.05 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 33.85 | 92.59 |
Price Performance
Historical ComparisonAbout PLBY PLBY Group Inc.
Playboy Inc, formerly PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.